Cargando…
mTOR-Inhibition and COVID-19 in Kidney Transplant Recipients: Focus on Pulmonary Fibrosis
Kidney transplant recipients are at high risk of developing severe COVID-19 due to the coexistence of several transplant-related comorbidities (e.g., cardiovascular disease, diabetes) and chronic immunosuppression. As a consequence, a large part of SARS-CoV-2 infected patients have been managed with...
Autores principales: | Granata, Simona, Carratù, Pierluigi, Stallone, Giovanni, Zaza, Gianluigi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8419255/ https://www.ncbi.nlm.nih.gov/pubmed/34497515 http://dx.doi.org/10.3389/fphar.2021.710543 |
Ejemplares similares
-
mTOR-inhibitors and post-transplant diabetes mellitus: a link still debated in kidney transplantation
por: Granata, Simona, et al.
Publicado: (2023) -
Skin cancer in solid organ transplant recipients: still an open problem
por: Granata, Simona, et al.
Publicado: (2023) -
Inflammasome pathway in kidney transplantation
por: Granata, Simona, et al.
Publicado: (2023) -
Proteomic analysis of urinary extracellular vesicles of kidney transplant recipients with BKV viruria and viremia: A pilot study
por: Bruschi, Maurizio, et al.
Publicado: (2022) -
Oxidative Stress and Ischemia/Reperfusion Injury in Kidney Transplantation: Focus on Ferroptosis, Mitophagy and New Antioxidants
por: Granata, Simona, et al.
Publicado: (2022)